Drug Shortage Report for LANTUS

Last updated on 2023-02-09 History
Report ID 182411
Drug Identification Number 02251930
Brand name LANTUS
Common or Proper name LANTUS CARTRIDGES
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN GLARGINE
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5
ATC code A10AE
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-01-23
Estimated end date 2023-02-10
Actual end date 2023-02-07
Shortage status Resolved
Updated date 2023-02-09
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2023-02-09 French Compare
v3 2023-02-09 English Compare
v2 2023-01-26 French Compare
v1 2023-01-26 English Compare

Showing 1 to 4 of 4